-
Last Night's Noteables July 12
Tuesday, July 12, 2011 - 8:51am | 303Upgrades Downgrades Intuitive Surgical, Inc. (ISRG) recent weakness a buying opportunity, says Madison Williams Annaly Capital Management (NLY) Leads Pre-Market Volume - Prices 120 Mln Share Offering at $17.70 Per Share Novellus Systems, Inc. (NVLS) Little light on revs, little better eps 350 vs...
-
Morgan Keegan's Favorite Ideas in the Hospital Supplies Group: Baxter, Covidien, and Hill-Rom
Tuesday, July 12, 2011 - 8:49am | 150Calendar second-quarter earnings for the hospital supplies group are scheduled to kick-off on July 19th, Morgan Keegan reports. “Going into earnings, our favorite long ideas are Outperform rated Baxter (NYSE: BAX) ($70 PT) and Covidien (NYSE: COV) ($63 PT), and Market Perform rated Hill-Rom...
-
Boston Scientific Completes Clinical Trial Enrollment for Adapt Monorail Carotid Stent System
Tuesday, July 12, 2011 - 8:32am | 96Boston Scientific Corporation (NYSE: BSX) has completed patient enrollment in the ASTI post-market clinical follow-up study designed to evaluate its Adapt™ Monorail™ Carotid Stent System in combination with its FilterWire EZ™ Embolic Protection System for treatment of carotid artery disease in...
-
Goldman Sachs Maintains Neutral on Hospira
Tuesday, July 12, 2011 - 8:25am | 152Goldman Sachs is out with its report today on Hospira (NYSE: HSP), maintaining Neutral. In a note to clients, Goldman Sachs writes, "Shifting to the long term, we think the company needs to bridge the gap between the slowing sales from Paragraph IV challenge drugs (2012) and the eventual impact...
-
St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Tuesday, July 12, 2011 - 8:05am | 52St. Jude Medical, Inc. (NYSE: STJ) today announced the U.S. Food and Drug Administration clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy. This first-of-its-kind system allows physicians to place multiple neurostimulation leads through a single...
-
St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Tuesday, July 12, 2011 - 8:04am | 270St. Jude Medical, Inc. (NYSE: STJ) today announced the U.S. Food and Drug Administration (FDA) clearance and limited market release of the Epiducer™ lead delivery system for neurostimulation therapy. This first-of-its-kind system allows physicians to place multiple neurostimulation leads through a...
-
Acacia Subsidiary Enters into Settlement Agreement with Boston Scientific Corporation
Tuesday, July 12, 2011 - 7:06am | 63Acacia Research Corporation (Nasdaq: ACTG) announced today that its EVM Systems, LLC subsidiary has entered into a settlement agreement with Boston Scientific Corporation (NYSE: BSX) regarding patents for shape memory metal medical instruments. The settlement agreement resolves litigation that...
-
Spectranetics Appoints Scott Drake as President and CEO
Tuesday, July 12, 2011 - 7:04am | 27Spectranetics Corporation (NASDAQ: SPNC) today announced the appointment of Scott Drake as President and Chief Executive Officer, effective August 10, 2011.
-
Spectranetics Appoints Scott Drake as President and Chief Executive Officer
Tuesday, July 12, 2011 - 7:00am | 27Spectranetics Corporation (NASDAQ: SPNC) today announced the appointment of Scott Drake as President and Chief Executive Officer, effective August 10, 2011.
-
Bank of America Provides Color on Kinetic Concepts
Tuesday, July 12, 2011 - 6:30am | 135Bank of America provided color on Kinetic Concepts (NYSE: KCI). In a research report published today, Bank of America commented on rumors the company might be acquired by private equity firms. In the report, Bank of America states, “Last week, several media outlets reported that KCI is in talks...
-
Stocks to Watch for Tuesday 07/12/11: Fresh 52 Week Highs and Lows
Monday, July 11, 2011 - 5:09pm | 1546Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Monday's trading session (listed from highest total volume to lowest): 1) BioSante Pharmaceuticals (NASDAQ: BPAX...
-
Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure
Monday, July 11, 2011 - 1:01pm | 162Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity® Catheter System™ for the treatment of resistant hypertension (high...
-
Monday's Put/Call Ratio Leaders
Monday, July 11, 2011 - 12:27pm | 78Here are today's Put/Call Ratio leaders… 1. Lender Processing Services (NYSE: LPS) 10,272 puts, 26 calls 2. Baxter International (NYSE: BAX) 3,581 puts, 264 calls 3. Arm Holdings (NASDAQ: ARMH) 9,045 puts, 1,028 calls 4. Infosys Limited (NASDAQ: INFY) 7,213 puts, 848 calls 5. HSBC Holdings (NYSE:...
-
Options Brief: Varian Medical Systems
Monday, July 11, 2011 - 10:19am | 79Shares of Varian Medical Systems (NYSE: VAR) are lower on the session by 0.16%, trading at $70.66. Overall call volume is now running at 4.20x the daily average, with 45% of all calls traded being purchases on the offer. 1,242 contracts have traded on the session so far. Varian Medical Systems,...
-
St. Jude Medical Receives FDA Approval for Expansion of BROADEN Deep Brain Stimulation Study for Depression
Monday, July 11, 2011 - 8:05am | 165St. Jude Medical, Inc. (NYSE: STJ) today announced that the U.S. Food and Drug Administration (FDA) has granted approval for expansion of its BROADEN™ (BROdmann Area 25 DEep brain Neurostimulation) study for depression. This expansion will allow a maximum of 20 sites across the U.S. to enroll up to...